Free Trial
OTCMKTS:FSNUY

Fresenius SE & Co. (FSNUY) Stock Price, News & Analysis

Fresenius SE & Co. logo
$14.80 0.00 (0.00%)
As of 11/13/2026 03:53 PM Eastern

About Fresenius SE & Co. Stock (OTCMKTS:FSNUY)

Advanced

Key Stats

Today's Range
$14.79
▼
$14.85
50-Day Range
$11.71
▼
$14.99
52-Week Range
$10.33
▼
$15.94
Volume
47,447 shs
Average Volume
99,169 shs
Market Capitalization
$33.34 billion
P/E Ratio
18.50
Dividend Yield
1.35%
Price Target
N/A
Consensus Rating
Buy

Company Overview

Fresenius SE & Co. KGaA is a German healthcare group headquartered in Bad Homburg. Its businesses include Fresenius Kabi, which supplies medicines, clinical nutrition, infusion therapies and medical technologies, and Fresenius Helios, which operates hospitals in Germany and Spain.

Fresenius Kabi serves healthcare providers around the world, while Helios focuses on hospital and healthcare services in Europe. The group traces its origins to a pharmacy in Frankfurt acquired by pharmacist Eduard Fresenius in 1912.

Michael Sen has served as Fresenius’s chief executive officer since 2022. Through its businesses, the company provides products and services across areas including hospital care, pharmaceuticals and medical technology.

AI Generated. May Contain Errors.

Fresenius SE & Co. Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
68th Percentile Overall Score

FSNUY MarketRank™: 
3.390515300035 of 5 stars

Fresenius SE & Co. scored higher than 68% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Fresenius SE & Co. has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on no strong buy ratings, 3 buy ratings, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Fresenius SE & Co. has only been the subject of 1 research reports in the past 90 days.

  • Read more about Fresenius SE & Co.'s stock forecast and price target.
  • Earnings Growth

    Earnings for Fresenius SE & Co. are expected to grow by 4.67% in the coming year, from $1.07 to $1.12 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Fresenius SE & Co. is 18.50, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 26.38.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Fresenius SE & Co. is 18.50, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 34.59.

  • Price to Book Value per Share Ratio

    Fresenius SE & Co. has a P/B Ratio of 1.49. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    0.00% of the float of Fresenius SE & Co. has been sold short.
  • Short Interest Ratio / Days to Cover

    Fresenius SE & Co. has a short interest ratio ("days to cover") of 0.32, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Fresenius SE & Co. has recently decreased by 85.35%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Fresenius SE & Co. pays a meaningful dividend of 1.37%, higher than the bottom 25% of all stocks that pay dividends.

  • Dividend Growth

    Fresenius SE & Co. does not have a long track record of dividend growth.

  • Dividend Coverage

    The dividend payout ratio of Fresenius SE & Co. is 25.00%. This payout ratio is at a healthy, sustainable level, below 75%.

  • Dividend Sustainability

    Based on earnings estimates, Fresenius SE & Co. will have a dividend payout ratio of 17.86% next year. This indicates that Fresenius SE & Co. will be able to sustain or increase its dividend.

  • Read more about Fresenius SE & Co.'s dividend.
  • News Sentiment

    Fresenius SE & Co. has a news sentiment score of 0.66. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Healthcare companies.
  • News Coverage This Week

    MarketBeat has tracked 2 news articles for Fresenius SE & Co. this week, compared to 1 article on an average week.
Receive FSNUY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Fresenius SE & Co. and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

FSNUY Stock News Headlines

Fresenius plans to sell around 13.4 million FMC shares
The warning signs most investors see too late
Dr. Martin D. Weiss has publicly predicted six major American crashes since founding Weiss Ratings in 1971. Now, after 55 years of market analysis, he says conditions are forming for a financial crisis that could rival or exceed 2008.tc pixel
Jefferies leaves Fresenius SE at 'Buy', target €55
Fresenius SE & Co. KGaA : JP Morgan reaffirms its Buy rating
Fresenius : Q3 2026 Aide Memoire available
See More Headlines

FSNUY Stock Analysis - Frequently Asked Questions

Fresenius SE & Co.'s stock was trading at $14.33 at the start of the year. Since then, FSNUY stock has increased by 3.3% and is now trading at $14.80.

Fresenius SE & Co. (OTCMKTS:FSNUY) issued its quarterly earnings data on Wednesday, November, 4th. The company reported $0.25 earnings per share for the quarter, beating the consensus estimate of $0.22 by $0.03. The firm earned $6.52 billion during the quarter, compared to analyst estimates of $6.51 billion. Fresenius SE & Co. had a trailing twelve-month return on equity of 10.24% and a net margin of 6.58%.

Shares of FSNUY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Fresenius SE & Co. investors own include Alibaba Group (BABA), Fresenius Medical Care AG & Co. KGaA (FMS), International Business Machines (IBM), Toll Brothers (TOL), Uber Technologies (UBER), Allianz (ALIZY) and Basf (BAS).

Company Calendar

Last Earnings
11/04/2026
Today
11/15/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Industry
Healthcare Equipment & Supplies
Sub-Industry
Healthcare Equipment
Current Symbol
OTCMKTS:FSNUY
CIK
904868
Fax
N/A
Employees
178,394
Year Founded
1912

Profitability

EPS (Trailing Twelve Months)
$0.80
Trailing P/E Ratio
18.50
Forward P/E Ratio
13.21
P/E Growth
N/A
Net Income
$1.43 billion
Net Margins
6.58%
Pretax Margin
9.53%
Return on Equity
10.24%
Return on Assets
4.94%

Debt

Debt-to-Equity Ratio
0.41
Current Ratio
1.28
Quick Ratio
0.97

Sales & Book Value

Annual Sales
$25.87 billion
Price / Sales
1.29
Cash Flow
$1.56 per share
Price / Cash Flow
9.46
Book Value
$9.93 per share
Price / Book
1.49

Miscellaneous

Outstanding Shares
2,252,950,000
Free Float
N/A
Market Cap
$33.34 billion
Optionable
Not Optionable
Beta
0.63

Social Links

10 Stocks Powering The Next AI Boom  Cover

The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation.

Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.

Get This Free Report

This page (OTCMKTS:FSNUY) was last updated on 11/13/2026 by MarketBeat.com Staff.
From Our Partners